T1000	Speculation 1133 1139	likely
E1000	Speculation:T1000 Scope:T1001
T1001	Span 1041 1221	Estrogen receptor-negative breast cancers with high NEUROD1 methylation were 10.8-fold more likely to respond with a complete pathologic response following neoadjuvant chemotherapy
T1002	Speculation 349 356	whether
E1001	Speculation:T1002 Scope:T1003
T1003	Span 349 453	whether NEUROD1 DNA methylation is able to predict the response to neoadjuvant and adjuvant chemotherapy
T1004	Speculation 1322 1331	indicated
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1322 1564	indicated poor relapse-free and overall survival in univariate and multivariate analyses (relative risk for relapse, 6.2; 95% confidence interval, 1.6-24; P = 0.008, and relative risk for death, 14; 95% confidence interval, 1.6-120; P = 0.02)
